Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

STERIS (STE) Stock Forecast & Price Target

STERIS logo
$245.26 +0.49 (+0.20%)
Closing price 03:59 PM Eastern
Extended Trading
$243.52 -1.74 (-0.71%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

STERIS - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy
Based on 8 Analyst Ratings
Sell
0
Hold
2
Buy
6

Based on 8 Wall Street analysts who have issued ratings for STERIS in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 2 have given a hold rating, and 6 have given a buy rating for STE.

Consensus Price Target

$273.50
11.51% Upside
According to the 8 analysts' twelve-month price targets for STERIS, the average price target is $273.50. The highest price target for STE is $295.00, while the lowest price target for STE is $250.00. The average price target represents a forecasted upside of 11.51% from the current price of $245.26.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for STE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for STERIS and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STE Analyst Ratings Over Time

TypeCurrent Forecast
8/29/24 to 8/29/25		1 Month Ago
7/30/24 to 7/30/25		3 Months Ago
5/31/24 to 5/31/25		1 Year Ago
8/30/23 to 8/29/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$273.50$270.33$263.83$243.60
Forecasted Upside11.51% Upside17.91% Upside7.65% Upside2.48% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

STE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

STERIS Stock vs. The Competition

TypeSTERISMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside11.73% Upside15,720.96% Upside10.25% Upside
News Sentiment Rating
Positive News

See Recent STE News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/8/2025Morgan Stanley
3 of 5 stars		Patrick Wood
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOverweight ➝ Overweight$276.00 ➝ $295.00+22.18%
7/22/2025KeyCorp
3 of 5 stars		Brett Fishbin
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOverweight ➝ Overweight$277.00 ➝ $288.00+28.78%
5/29/2025Jefferies Financial Group
2 of 5 stars		David Windley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageHold$263.00+7.33%
5/16/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform
5/16/2025JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Turkaly
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetMarket Outperform ➝ Market Outperform$265.00 ➝ $280.00+11.84%
5/15/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating		S. Etoch
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$250.00 ➝ $250.00+1.92%
4/7/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Mike Matson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingHold ➝ Hold
2/3/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		J. Bednar
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOverweight ➝ Overweight$260.00 ➝ $265.00+21.26%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:34 PM ET.


Should I Buy STERIS Stock? STE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, August 24, 2025. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STERIS
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in STERIS plc:

  • Recent upgrades from multiple analysts, including a target price increase to $288.00, indicate strong market confidence in STERIS plc's growth potential.
  • The current stock price is around $273.50, which reflects a favorable valuation compared to the consensus target price set by analysts.
  • STERIS plc has a solid dividend yield of approximately 1.0%, providing investors with a steady income stream alongside potential capital appreciation.
  • With a payout ratio of 34.92%, the company maintains a healthy balance between returning profits to shareholders and reinvesting in growth opportunities.
  • The company operates in essential sectors such as Healthcare and Life Sciences, which are likely to see continued demand, especially in the context of ongoing global health challenges.

STERIS
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in STERIS plc for these reasons:

  • Despite positive analyst ratings, the stock has shown volatility, which may pose risks for investors seeking stability.
  • Market conditions can impact the performance of STERIS plc, particularly in sectors sensitive to economic fluctuations.
  • While the dividend has increased, any future cuts or stagnation in dividend growth could deter income-focused investors.
  • Competition in the infection prevention and sterilization market is intense, which could pressure margins and growth prospects.
  • Analyst ratings can change rapidly based on market conditions, and reliance on these ratings may not always reflect the company's long-term performance.

STE Forecast - Frequently Asked Questions

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for STERIS is $273.50, with a high forecast of $295.00 and a low forecast of $250.00.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" STE shares.

According to analysts, STERIS's stock has a predicted upside of 11.51% based on their 12-month stock forecasts.

Over the previous 90 days, STERIS's stock had 1 upgrade by analysts.

STERIS has been rated by research analysts at KeyCorp, and Morgan Stanley in the past 90 days.

Analysts like STERIS less than other "medical" companies. The consensus rating score for STERIS is 2.75 while the average consensus rating score for "medical" companies is 2.78. Learn more on how STE compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NYSE:STE) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsoredtc pixel
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsoredtc pixel